Background Nicorandil has been reported to induce cardioprotection by opening the mitochondrial KATP channels. However, whether nicorandil affects reactive oxygen species is unclear.
Methods and Results
The hearts of male Sprague-Dawley rats were excised and perfused on a Langendorff apparatus with Krebs-Henseleit solution with a gas mixture of 95% O2 and 5% CO2. 1 mmol/L of nicorandil was given 10 min before ischemia. Left ventricular developed pressure (LVDP, mmHg), ±dP/dt (mmHg/s) and coronary flow (ml/min) were continuously monitored. All hearts were perfused for a total of 120 min consisting of a 30 min pre-ischemic period, followed by a 30 min global ischemia and 60 min reperfusion with and without 5-hydroxydecanoic acid sodium salt (5-HD), a mitochondrial KATP channel blocker. The concentrations of 2,3-dihydroxybenzoic acid (2,3-DHBA), an indicator of hydroxyl radicals, in the perfusate during reperfusion period were also measured. Nicorandil significantly improved LVDP and ±dP/dt, and increased coronary flow during reperfusion. Pretreatment with 5-HD abolished the improvement of LVDP and ±dP/dt, and the increase in coronary flow induced by nicorandil. Nicorandil significantly attenuated the concentrations of 2,3-DHBA during reperfusion, which were restored by 5-HD. Conclusion Nicorandil is protective against post-ischemic left ventricular dysfunction in association with opening the mitochondrial KATP channels, decreasing hydroxyl radicals and increasing coronary flow in the isolated rat heart. (Circ J 2006; 70: 1650 -1654) Key Words: Hydroxyl radicals; Mitochondrial KATP channels; Myocardial dysfunction; Nicorandil I tube was inserted into the left ventricle through the apex and connected to a pressure transducer and adjusted to a left ventricular (LV) end-diastolic pressure of 5 mmHg during the initial equilibration. This preload volume was held constant during the entire experiment to allow continuous recording of the ventricular pressure. Pacing wires were fixed to the pulmonary outflow tract, and the hearts were paced at 320 beats/min except during ischemia. LV developed pressure (LVDP, end-systolic minus end-diastolic pressure, mmHg) and ±dP/dt (mmHg/s) were continuously monitored. Coronary flow (ml/min) was continuously measured by timed collection of the effluent. The perfusate was not recycled.
Experimental Protocol of Cardiac Function
All hearts were perfused for a total of 120 min consisting of a 30 min pre-ischemic period, followed by a 30 min global ischemia and 60 min reperfusion at a temperature of 37°C. As shown in Fig 1, 4 groups were studied: control group (n=10), hearts treated with saline; the nicorandil group (n=10), hearts treated with 1 mmol/L of nicorandil; the nicorandil +5-hydroxydecanoic acid sodium salt (5-HD) group (n=10), hearts treated with 100 mol/L of 5-HD during the 10 min of pre-ischemic period in the nicorandil group; and the 5-HD group (n=10), hearts treated with 100 mol/L of 5-HD during the 10 min of pre-ischemic period.
Measurement of Hydroxyl Radicals
The 2,3-dihydroxybenzoic acid (2,3-DHBA), an indicator of hydroxyl radicals, was measured using a high performance liquid chromatography coupled with electrochemical detection in the control group (n=10), nicorandil group (n=10), nicorandil +5-HD group (n=10), and 5-HD group (n=10). This method is based on the chemical reaction of salicylic acid with hydroxyl radicals, yielding 2,3-DHBA, 2,5-DHBA and catechol as its derivatives in an approximate proportion of 49%, 40% and 11%, respectively. 10 It is reported that salicylic acid with a concentration of 1 mmol/L traps approximately 10% of the theoretically possible hydroxyl radicals formed in vivo. 11 We used 2,3-DHBA as an indicator of hydroxyl radicals in the present study. The experimental procedure for the measurement of 2,3-DHBA was the same as described above, except that the hearts were perfused with the buffer containing 1 mmol/L salicylic acid. The pH of the buffer was re-adjusted after the addition of salicylic acid. Then, the hearts were subjected to global ischemia for 30 min and were reperfused for 30 min. The effluent was collected at the end of the perfusion and at 1, 2, 3, 5, 10, 15 and 30 min in the reperfusion period and stored at -80°C until assay with high performance liquid chromatography coupled with electrochemical detection (Coulochem II, MC Medical, Tokyo, Japan).
Statistical Analysis
All values are presented as the means ± SEM. The difference in hemodynamic variables over the time course between the control and the drug-treated groups was assessed by 2-way repeated measures analysis of variance. Student's t-test was used to assess the differences between the 2 groups. Differences with p<0.05 were considered statisti- 
Chemicals Used
Five-HD was purchased from Sigma Chemical (St Louis, MO, USA). Nicorandil was generously donated by Chugai Pharmaceutical Company (Tokyo, Japan).
Results

Effect of Nicorandil on Post-Ischemic Recovery of LV Function
During the pre-ischemic period, all measured parameters such as LVDP, ±dP/dt and coronary flow were comparable between the groups. 
Effect of Nicorandil on 2,3-DHBA Concentration, an Indicator of Hydroxyl Radicals, in the Effluent
As shown in Fig 5, 
Discussion
The present findings show that: (i) treatment with nicorandil significantly improved the recovery of LVDP and ±dP/dt during reperfusion after 30 min of global ischemia; (ii) the effect of nicorandil was blocked by pretreatment with a KATP channel blocker, 5-HD; and (iii) nicorandil significantly prevented the release of 2,3-DHBA in the effluent during reperfusion. Pretreatment with 5-HD restored the attenuation of 2,3-DHBA concentration by nicorandil.
Treatment with nicorandil significantly improved the post-ischemic myocardial dysfunction in the present study, which is consistent with results from other studies showing that nicorandil improves the post-ischemic myocardial dysfunction. 12, 13 First, it was clearly shown that treatment with nicorandil significantly attenuated the rise in 2,3-DHBA concentration, an indicator of hydroxyl radicals, in the effluent during reperfusion compared with the control, suggesting that nicorandil inhibited the production of hydroxyl radicals in the heart during reperfusion. It has been reported that postischemic myocardial dysfunction is mediated at least in part through the generation of ROS, such as superoxide anion, hydrogen peroxide and hydroxyl radical. 9 Among these, hydroxyl radical is reported to play the most important role in post-ischemic myocardial dysfunction. 9,14,15 Therefore, it might be possible that the improvement of cardiac function by nicorandil is because of the blockade of hydroxyl radical during reperfusion. Furthermore, attenuation of the concentration of 2,3-DHBA during reperfusion by nicorandil was restored by the treatment with 5-HD, a mitochondrial KATP channel blocker, suggesting that the opening of mitochondrial KATP channels reduces the production of hydroxyl radicals during reperfusion. This result is consistent with the findings by Ozcan et al 16 and Ferranti et al17 who suggested that the opening of mitochondrial KATP channels decreases the generation of ROS. However, Pain et al 6 and Forbes et al 7 reported that the opening of mitochondrial KATP channels produces the generation of ROS. 6, 7 Furthermore, Obata and Yamanaka reported that nicorandil increases the concentration of 2,3-DHBA in the rat myocardium and that the increased myocardial interstitial 2,3-DHBA concentration induced by 15 min ischemia was blocked by 5-HD or glibenclamide, suggesting that the blockade of cardiac mitochondrial KATP channels reduces hydroxyl radicals in the myocardium. 18 The discrepancies between these reports and ours might be explained by the difference in the amount of ROS generated during ischemia and reperfusion. It has been reported that ischemic preconditioning, a brief episode of ischemia and reperfusion, opens the mitochondrial KATP channels and produces free radicals and triggers the ischemic preconditioned state. 6, 7, 19 The amount of ROS produced by ischemic preconditioning by the short period of ischemia and reperfusion is considered to be small but that produced by prolonged ischemia and reperfusion is a larger burst of ROS. 9, 20 Therefore, it is conceivable that the opening of the mitochondtial KATP channels by nicorandil produces a small amount of ROS but suppresses a large amount of ROS production during reperfusion.
The baseline 2,3-DHBA concentration without ischemia was decreased in the nicorandil group. This suggests that nicorandil by itself can scavenge hydroxyl radicals. This is consistent with the previous report showing that nicorandil by itself scavenged hydroxyl radicals produced by hypoxanthine plus xanthine oxidase in the presence of iron. 21 However, the decrease in 2,3-DHBA concentration in the effluent after treatment with nicorandil might be at least in part a result of the dilution of the solution induced by an increase of coronary flow. The increase of coronary flow might have increased the washout rate of hydroxyl radicals produced in the myocardium then decreased the damage by hydroxyl radicals at a local site of the myocardium.
There is still the question of whether the decrease in 2,3-DHBA by nicorandil is the cause or the result of attenuating the ischemia -reperfusion injury. To solve this, it is reasonable to examine the effect of antioxidants on postischemic cardiac dysfunction. However, previous studies have shown that antioxidant drugs improve post-ischemic cardiac dysfunction in isolated hearts. 22, 23 Therefore, because nicorandil has been reported to have many beneficial effects, such as opening the mitochondrial KATP channels, 4, 5 inhibiting apoptosis, 24 inhibiting platelet aggregation, 25 direct preservation of mitochondrial function, 26 and coronary capillary architecture and volume, 27 besides free radical scavenging effects, it is still difficult to say whether the decrease in 2,3-DHBA concentration is the main cause of the attenuation of ischemia -reperfusion injury.
Second, it is suggested that the cardioprotective effect of nicorandil is based on the opening of the mitochondrial KATP channels in the cardiac myocytes, because the improvement in myocardial dysfunction after global ischemia by nicorandil was completely abolished by pretreatment with a mitochondrial KATP channel blocker, 5-HD, in the present study. At present, it is widely accepted that opening of the mitochondrial KATP channels is critically important in protecting the myocardium against ischemic injury. [28] [29] [30] Third, the present study shows that nicorandil significantly increased the coronary flow during reperfusion as compared with the control. The increase in coronary flow during reperfusion by nicorandil was restored by the treatment with 5-HD, a mitochondrial KATP channel blocker, suggesting that opening of the mitochondrial KATP channels increases the coronary flow. The increase in coronary flow could have improved the post-ischemic myocardial dysfunction. In the present study, a mitochondrial KATP channel blocker 5-HD abolished the increase in coronary flow in the isolated hearts. Because coronary flow is determined by perfusion pressure/arterial resistance, under the condition that perfusion pressure was kept constant at 80 mmHg in the present study, coronary flow is predominantly determined by arterial resistance, which is predominantly influenced by small arteries rather than large arteries. It has been reported that there is heterogeneity in the vasodilating effect of nicorandil on coronary arteries; nicorandil behaves predominantly as a nitrate in large coronary arteries and behaves as a KATP channel opener in small arteries. 31 Furthermore, it has been reported that a nitric oxide donor, such as isosorbide dinitrate, increases the diameter of large coronary arteries without affecting coronary blood flow at low doses and increases both coronary diameter and blood flow at higher doses. 32 The increase in coronary flow by nicorandil was inhibited by the 5-HD but the curve tended to be situated at higher position in the nicorandil +5-HD group than in the control group, although not significant statistically as shown in Fig 5. This suggests that this difference might be a result of the nitrate action of nicorandil.
Among many KATP channel openers, nicorandil is the only KATP channel opener that is currently used clinically, and its use has been reported to be associated with better clinical and functional outcomes in patients with acute myocardial infarction. 33, 34 The beneficial effect of nicorandil might be at least in part a result of its effect to decrease the production of hydroxyl radicals.
In conclusion, nicorandil is protective against postischemic LV dysfunction in association with opening the mitochondrial KATP channels, decreasing hydroxyl radicals and increasing coronary flow in the isolated rat heart.
